Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    The Lancet Date published:

  • Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial

    Nephrology Date published:

  • Effect of extended hours dialysis on sleep quality in a randomized trial

    Nephrology Date published:

  • Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

    Diabetologia Date published:

  • Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study

    PLOS One Date published:

  • Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis

    Diabetes, Obesity and Metabolism Date published:

  • Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial

    Canadian Medical Association Journal Date published:

  • EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE OUTCOMES WITH AND WITHOUT PRESERVED EJECTION FRACTION IN TYPE 2 DIABETES: RESULTS FROM THE CANVAS PROGRAM

    Journal of the American College of Cardiology Date published:

  • Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

    BMJ Open Date published:

  • Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

    The Lancet Diabetes & Endocrinology Date published:

  • Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

    The Lancet Diabetes & Endocrinology Date published:

  • Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium

    American Journal of Kidney Diseases Date published:

  • Canagliflozin and Stroke in Type 2 Diabetes Mellitus

    Stroke Date published:

  • Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA

    Circulation Date published:

  • Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

    Clinical Journal of the American Society of Nephrology Date published:

  • Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

    BMJ Date published: